TRUTAKNA® (atacicept) has been FDA approved for IgAN, click to learn more. FILSPARI® (sparsentan) has also been FDA approved for FSGS and more information is coming soon. Please visit our Patient Navigation tool for support.
Empowering Students with Kidney Disease covers educational, developmental, and mental health aspects for families of K-12 students with kidney disease.
Dr. Doyle’s research and advocacy focuses on living with rare and chronic health conditions across the lifespan, with a special interest in emerging adulthood and the transition from pediatric to adult-oriented care.
Visit our Youtube page
NephCure is a registered non-profit (501c3) tax-exempt charitable organization. EIN # 38-3569922.
© Copyright 2024 NephCure, Inc. All rights reserved worldwide. NephCure, and the logo, are federally registered trademarks of NephCure, Inc.
EN 
ES 
